Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
ALEMBIC PHARMACEUTICALS LTD.
Alembic Pharmaceuticals Ltd.
NSE: APLLTD | BSE: 533573
Mid-range Performer
In 5 Starfolio Baskets
Download real time
US FDA Inspections
818.30
3.85
(
0.47
%)
28.70% Gain from 52W Low
74,178
NSE+BSE Volume
NSE
28 Jul, 2026 3:15 PM (IST)
Watchlist
Portfolio
Alert
My Notes
US FDA Approval
Alembic Pharma receives US FDA approval for a constipation drug, with a market size of $100 million
See details
Overview
Buy Sell Zone
Financials
Forecaster
Competitors/Peers
Quarterly Results
Annual Results
Balance Sheet
Financial Ratios
Cash Flow
Documents
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Alembic Pharma - Competitors/Peers Analysis